Tag: FTC pharmaceutical competition

Patent Litigation: How Authorized Generics Reduce Generic Drug Competition

Authorized generics let brand drug companies launch their own generic versions, undercutting independent competitors during the 180-day exclusivity window. This practice reduces price drops, discourages patent challenges, and harms true competition in the pharmaceutical market.